Merdury Biopharmaceutical Corporation

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

N/A

Website

merdury.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2019New Taipei City, Taiwan

Merdury Biopharmaceutical develops drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development technology platform that integrates drug formulation, 3D powder printing, and hardware and software technologies to create drug-specific 3D printing production equipment, which can be used as a foundation for pharmaceutical companies to provide hosted services and in-house product development Formulation design and 3D pharmaceutical processing services. Founded in 2019, Merdury Biopharmaceutical is headquartered in New Taipei City, Taiwan.

Key Stats

52-Week Range

NT$4.95NT$12.20

Beta-1.22

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.16

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.